Postoperative chemoradiotherapy versus radiotherapy alone for cervical cancer: A systematic review and meta-analysis

References

• Chatani M, Nose T, Masaki N, Inoue T. 1998. Adjuvant radiotherapy after radical hysterectomy of the cervical cancer. Strahlentherapie Und Onkologie 174:504–509.
   PubMed Web of Science ®Google Scholar
• Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. 2008. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. Journal of Clinical Oncology 26:5802–5812.
   PubMed Web of Science ®Google Scholar
• Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration. 2010. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis. The Cochrane Database of Systematic Reviews 20:CD008285.
   Google Scholar
• DerSimonian R, Kacker R. 2007. Random-effects model for meta-analysis of clinical trials: an update. Contemporary Clinical Trials 28:105–114.
   PubMed Web of Science ®Google Scholar
• Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, et al. 2004. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. Journal of Clinical Oncology 22:872–880.
   PubMed Web of Science ®Google Scholar
• Green, J, Kirwan, J, Tierney, J, Vale, C, Symonds, P, Fresco, L, et al. 2005. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. The Cochrane Database of Systematic Reviews 4:CD002225.
   Google Scholar
• Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, Williams CJ. 2001. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. The Lancet 358:781–786.
   PubMed Web of Science ®Google Scholar
• Higgins, JP, Green, S, The Cochrane Collaboration. 2008. Cochrane handbook for systematic reviews of interventions. Chichester: Wiley Online Library.
   Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. 2003. Measuring inconsistency in meta-analyses. British Medical Journal 327:557–560.
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. 2011. Global cancer statistics. CA: A Cancer Journal for Clinicians 61:69–90.
   PubMed Web of Science ®Google Scholar
• Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL, et al. 1999. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. New England Journal of Medicine 340:1154–1161.
   PubMed Web of Science ®Google Scholar
• Kim K, Kang S, Chung H, Kim J, Park N, Song Y. 2009. Comparison of chemoradiation with radiation as postoperative adjuvant therapy in cervical cancer patients with intermediate-risk factors. European Journal of Surgical Oncology 35:192–196.
   PubMed Web of Science ®Google Scholar
• Klopp AH, Eifel PJ. 2011. Chemoradiotherapy for cervical cancer in 2010. Current Oncology Reports 13:77–85.
   PubMed Web of Science ®Google Scholar
• Kodaira T, Fuwa N, Nakanishi T, Kuzuya K, Sasaoka M, Furutani K, Kamata M. 2002. Retrospective analysis of postoperative radiotherapy for node-negative cervical carcinoma with stage IB–IIB disease. Japanese Journal of Clinical Oncology 32:255–261.
   PubMed Web of Science ®Google Scholar
• Lee TY, Jeung YJ, Lee CJ, Kim HY, Kim SH, Kim WG. 2013. Promising treatment results of adjuvant chemotherapy following radical hysterectomy for intermediate risk stage 1B cervical cancer. Obstetrics & Gynecology Science 56:15–21.
   PubMedGoogle Scholar
• Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. 2009. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Annals of Internal Medicine 151:W-65–W-94.
   Web of Science ®Google Scholar
• Lim A, Sia S. 2012. Outcomes of chemoradiotherapy in cervical cancer – the Western Australian experience. International Journal of Radiation Oncology, Biology, Physics 82:1431–1438.
   PubMed Web of Science ®Google Scholar
• Lukka H, Hirte H, Fyles A, Thomas G, Elit L, Johnston M, et al. 2002. Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer – a meta-analysis. Clinical Oncology: A Journal of the Royal College of Radiologists 14:203–212.
   Google Scholar
• Micha JP, Goldstein BH, Rettenmaier MA, Brown JV, III, John CR, Markman M. 2006. Surgery alone or surgery with a combination radiation or chemoradiation for management of patients with bulky-stage IB2 cervical carcinoma. International Journal of Gynecological Cancer 16:1147–1151.
   PubMed Web of Science ®Google Scholar
• Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, et al. 1999. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. New England Journal of Medicine 340:1137–1143.
   PubMed Web of Science ®Google Scholar
• Muderspach LI, Curtin JP, Roman LD, Gebhardt JA, Klement V, Qian D, et al. 1997. Carboplatin as a radiation sensitizer in locally advanced cervical cancer: a pilot study. Gynecologic Oncology 65:336–342.
   PubMed Web of Science ®Google Scholar
• Okazawa M, Mabuchi S, Isohashi F, Suzuki O, Yoshioka Y, Sasano T, et al. 2013. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience. International Journal of Gynecological Cancer 23:567–575.
   PubMed Web of Science ®Google Scholar
• Pearcey R, Brundage M, Drouin P, Jeffrey J, Johnston D, Lukka H, et al. 2002. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. Journal of Clinical Oncology 20:966–972.
   PubMed Web of Science ®Google Scholar
• Peters, W, Liu, P, Barret, R. 1999. Cisplatin, 5-fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive therapy in high-risk, early-stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy. Gynecologic Oncology 72:443.
   PubMedGoogle Scholar
• Peters WA, Liu P, Barrett RJ, Stock RJ, Monk BJ, Berek JS, et al. 2000. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. Journal of Clinical Oncology 18:1606–1613.
   PubMed Web of Science ®Google Scholar
• Rose P. 2002. Chemoradiotherapy for cervical cancer. European Journal of Cancer 38:270–278.
   PubMed Web of Science ®Google Scholar
• Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, et al. 1999. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. New England Journal of Medicine 340:1144–1153.
   PubMed Web of Science ®Google Scholar
• Ryu HS, Chun M, Chang KH, Chang HJ, Lee JP. 2005. Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients. Gynecologic Oncology 96:490–495.
   PubMed Web of Science ®Google Scholar
• Silva IH, Nogueira-Silva C, Figueiredo T, Lombo L, Faustino I, Catarino R, et al. 2013. The impact of GGH-401C > T polymorphism on cisplatin-based chemoradiotherapy response and survival in cervical cancer. Gene 512:247–250.
   PubMed Web of Science ®Google Scholar
• Song S, Song C, Kim HJ, Wu HG, Kim JH, Park NH, et al. 2012. 20 year experience of postoperative radiotherapy in IB-IIA cervical cancer patients with intermediate risk factors: impact of treatment period and concurrent chemotherapy. Gynecologic Oncology 124:63–67.
   PubMed Web of Science ®Google Scholar
• Spensley S, Hunter RD, Livsey JE, Swindell R, Davidson SE. 2009. Clinical outcome for chemoradiotherapy in carcinoma of the cervix. Clinical. Clinical Oncology: A Journal of the Royal College of Radiologists 21:49–55.
   PubMed Web of Science ®Google Scholar
• Takeshita S, Kita T, Motoike Y, Umezawa K, Sugisaki S, Matsumoto S, et al. 2010. Postoperative concurrent chemoradiotherapy for the high-risk uterine cervical cancer. Journal of Obstetrics and Gynaecology Research 36:1009–1014.
   PubMed Web of Science ®Google Scholar
• The Cochrane Collaboration. 2012. Review Manager (RevMan) [Computer Program]. Version 5.2. Copenhagen: The Nordic Cochrane Centre.
   Google Scholar
• Thomas GM. 1999. Improved treatment for cervical cancer-concurrent chemotherapy and radiotherapy. The New England Journal of Medicine 340:1198–1200.
   PubMed Web of Science ®Google Scholar
• Uno T, Ito H, Itami J, Yasuda S, Isobe K, Hara R, et al. 1999. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors. Anticancer Research 20:2235–2239.
   Web of Science ®Google Scholar
• Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC, Jr, et al. 1999. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. Journal of Clinical Oncology 17:1339–1339.
   PubMed Web of Science ®Google Scholar